Platelet Products and Artificial Platelets for Regenerative Medicine
Authors:
Open Access
- 3 July 2026
- journal article
- review article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- p. 1-19
Abstract
Platelet products derived from whole blood include platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet lysate (PL) and platelet-derived extracellular vesicles (pEVs). Such products have been utilized for hemostatic purposes and regenerative medicine. Poor shelf life, high cost of storage, immune risk, and constant need for adequate donors has led to the desire for biomaterials that mimic platelet function. Artificial platelets, such as platelet-membrane coated nanoparticles (NPs), platelet-like particles (PLPs), SynthoPlate, and GRGDS-PEG-coated polyurethane NPs, have been designed to mimic platelet functionality and aid in hemostasis. However, their function can be further leveraged for regenerative medicine and wound healing as they interact with activated platelets and fibrin at the region of interest, highlighting their therapeutic potential. Example regenerative applications of both platelet products and artificial platelets include osteogenesis, angiogenesis, soft tissue and dermal healing, and drug or cell delivery. Some instances in platelet products have reached clinical trials, but most of the biomaterial applications in this realm are still in preclinical testing. Research into their regenerative and wound healing capabilities is novel for the field, but the products show tremendous promise in biomedical applications beyond hemostasis.Keywords
This publication has 95 references indexed in Scilit:
- Fusing Biomimetic Engineering with Nanotechnology: The Rise of Platelet Membrane‐Coated Nanoparticles as a Versatile Platform for Biomedical InnovationAdvanced Therapeutics, 2025
- Noninvasive Fibrin Targeting Colloid‐Mediated Intra‐Articular RepairJournal of Biomedical Materials Research Part A, 2025
- Noninvasive platelet membrane‐coated Fe3O4 nanoparticles identify vulnerable atherosclerotic plaquesSmart Medicine, 2024
- Intra-Articular Platelet-Rich Plasma Injection After Anterior Cruciate Ligament ReconstructionJAMA Network Open, 2024
- First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healingJournal of Extracellular Vesicles, 2023
- Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients With Ankle OsteoarthritisJAMA, 2021
- Platelet‐like particles reduce coagulopathy‐related and neuroinflammatory pathologies post‐experimental traumatic brain injuryJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2021
- Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis ModelsAdvanced Materials, 2019
- Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non‐cemented hip prosthesis integrationJournal of Orthopaedic Research, 2011
- Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone MarrowStem Cells, 2009